Log In
BCIQ
Print this Print this
 

Dacogen, decitabine (E7373)

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionHypomethylating agent (HMA)
Molecular Target DNA methyltransferase
Mechanism of ActionDNA methyltransferase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$866.0M

0

$866.0M


 Deals Details
Get a free BioCentury trial today